User: Guest

  



DOMAIN EXPERT ENGAGEMENTS

Number of executives repeatedly engaged by snail & email outreach*

POOL + OUTREACH

4017

Interactions with Platform & by Email *

INTERACTIONS

723

Unique # Participated *

PARTICIPANTS

121

Responses Validated *

VALIDATIONS

35

* Platform engagements are dynamic. Stats are published quarterly.


  •  CODE

  •  PAGES

  •  DATE

  •  PRICE

    $

  •  DATA EXHIBITS

    125


TABLE OF CONTENTS


   Pages :    | $

   Study Reliability and Reporting Limitations.....I-1  
   Disclaimers.....I-2
Data Interpretation & Reporting Level.....I-2
  
   Quantitative Techniques & Analytics.....I-3
Product Definitions and Scope of Study.....I-3
Medical Bioimaging.....I-3
  
   Molecular Bioimaging.....I-4  
   Medical Imaging: A Established Discipline.....II-5
Innovations Foster Medical Imaging Market.....II-5
1$100
   Growth in the Face of Adversities.....II-6
Current and Future Analysis.....II-6
1$100
   Growth Drivers.....II-7
Major Challenges.....II-7
Global Market Scenario for Molecular Bioimaging Systems.....II-7
1$100
   Molecular Imaging Equipment for Cardiology Sector.....II-8
Technological Innovations Spur Growth in Medical Imaging Market.....II-8
1$100
   Portable Technology Gains Popularity.....II-9
Hybrid Imaging: Integrating the Best.....II-9
1$100
   Systems Designs Aid in Developing New Devices.....II-10
Pill Camera: An Ingestible Device.....II-10
Women’s Health Imaging Market to Register Growth.....II-10
Market Trends.....II-10
Bioinformatics Industry Require Bioimaging Technologies.....II-10
Healthcare IT Promises Further Growth.....II-10
1$100
   Preference for Advanced Device Technology.....II-11
CAD Software to Extend Capability.....II-11
Bioimaging Market: Benefiting from Pharmaceutical R&D Needs.....II-11
1$100
   Inadequate Technical Infrastructure – A Major Bottleneck.....II-12
Competitive Landscape.....II-12
1$100
   Recession Intensifies M&A Activity in the Medical Imaging Market.....II-131$100
   Ultrasound Equipment Market: A Review.....II-14
Impact of Recession.....II-14
1$100
   Innovations Continue to Support Industry Growth.....II-15
Non-Invasive & Radiation-Free: Benefits of Ultrasound Imaging.....II-15
Handheld Ultrasound Devices Gain Popularity.....II-15
1$100
   Handheld Echocardiographs: Future of Cardiac Ultrasound Imaging.....II-16
Miniature Echocardiography Systems.....II-16
Focus Shifts to Automated Image Analysis.....II-16
The Promise of 4D Imaging.....II-16
1$100
   Competitive Landscape.....II-17
CT Imaging Market.....II-17
Impact of Recession.....II-17
1$100
   Developing Markets: Vast Potential for Growth.....II-18
Multi-Detector CT Technology Gains Importance in Cardiology.....II-18
Focus Shifts to Reducing Radiation Risk.....II-18
1$100
   Nuclear Imaging Equipment Market.....II-19
Recession Hits Growth Prospects in Mature Nuclear Medicine Market.....II-19
Shifts towards Hybrid Imaging Systems.....II-19
1$100
   Technological Innovations Promise Bright Prospects.....II-20
Image-Guided Interventions – Driving Growth in Nuclear Medicine Arena.....II-20
Clinical Application Areas.....II-20
1$100
   Enormous Market Potential.....II-21
Competitive Landscape.....II-21
An Insight into PET and SPECT Market.....II-21
1$100
   Reimbursement: A Vital Factor.....II-22
MRI Equipment Market.....II-22
Steady Growth in MRI Imaging Market.....II-22
1$100
   Growth Drivers & Market Restraints.....II-23
MRI Market Feels the Pinch of Recession.....II-23
Growth Trends in Various Regional Markets.....II-23
Technological Advancements Boost MRI Market.....II-23
1$100
   Functional MRI – The Superior Technique.....II-24
Growing Popularity of 3T Scanners.....II-24
1$100
   Automated Scanning Technology – A Boon for Patients.....II-25
Dedicated MRI Systems – Quality Imaging at Affordable Prices.....II-25
Whole-Body and Black Blood Systems: Improving Diagnostic Abilities.....II-25
Open MRI – Continues to Make Rapid Strides.....II-25
1$100
   Breast MRI Systems.....II-26
High Diagnostic Value.....II-26
High-Field 3.0T Systems: Enabling Accurate Breast Imaging.....II-26
Competitive Landscape in the MRI Market.....II-26
1$100
   Table 1: Leading Players in the Global MRI Market (2010): Percentage Share Breakdown of Revenues for Siemens Healthcare, GE Healthcare, Philips Healthcare, and Others (includes corresponding Graph/Chart).....II-27
Fluoroscopy and Mobile C-Arms Market.....II-27
Developing Markets to Spur Growth.....II-27
Growth Wavers under Pressure from the Recession.....II-27
1$350
   Addressing Radiation Exposure Concerns.....II-28
Obese Patients Drive New Design Developments.....II-28
Competitive Scenario.....II-28
Global PACS Market.....II-28
1$100
   Developments in Signal Processing.....II-29
Novel Imaging Modalities for Breast Cancer Diagnosis.....II-29
Ultrasound /Breast Tomosynthesis System.....II-29
PAT System.....II-29
1$100
   BLUCI System.....II-30
Imaging Agents - A Quick Primer.....II-30
1$100
   Growth Drivers & Market Restraints.....II-31
Significance of Technological Advancements.....II-31
1$100
   X-Ray Contrast Media: Giving Way to Emerging Modalities.....II-32
Significant Growth Ahead.....II-32
Medical Reimbursements: A Critical Factor.....II-32
1$100
   Market Structure.....II-331$100
   Bioimaging: An Introduction.....II-34
Types of Bioimaging Techniques.....II-34
Medical Bioimaging Techniques.....II-34
1$100
   Types of Medical Bioimaging Techniques.....II-35
Nano-Bioimaging.....II-35
Radiological Imaging.....II-35
Disadvantages of Radiological Imaging.....II-35
Optical Imaging.....II-35
1$100
   Confocal, Optical and Fluorescence Microscopy.....II-36
Magnetic Resonance Imaging (MRI) and Ultrasound.....II-36
Optical Coherence Tomography (OCT).....II-36
1$100
   Molecular Bioimaging Techniques.....II-37
Operating Principle.....II-37
Current and Future Developments in Molecular Bioimaging.....II-37
1$100
   Application of Bioimaging in Drug Development.....II-38
Molecular Imaging in Drug Development.....II-38
1$100
   Major Molecular Imaging Technologies Used in Drug Development Process.....II-39
Development of New Biopharmaceuticals: An Opportunity.....II-39
1$100
   X-Ray Imaging.....II-40
Computed Tomography (CT) Imaging.....II-40
Working Principle of CT Imaging.....II-40
1$100
   Types of CT Scanning Systems.....II-41
Single Slice CT Scanners.....II-41
Multi Slice CT Scanners.....II-41
1$100
   Nuclear Medicine.....II-42
An Introduction.....II-42
1$100
   Nuclear Medicine Scans.....II-432$125
   Radioisotopes: Essential for Nuclear Medicine Procedure.....II-451$100
   Nuclear Medicine Imaging Equipment.....II-46
Positron Emission Tomography (PET).....II-46
Working Principle of PET Imaging.....II-46
1$100
   Applications of PET Systems.....II-47
PET in Brain Imaging.....II-47
Advantages of PET Over Other Imaging Procedures.....II-47
PET Vs SPECT.....II-47
1$100
   Gamma Cameras.....II-48
Single Photon Emission Computed Tomography (SPECT).....II-48
1$100
   Ultrasound Imaging.....II-49
Contrast and Resolution of Ultrasound Image.....II-49
Ultrasound Molecular Imaging.....II-49
1$100
   Magnetic Resonance Imaging (MRI) Imaging Equipment.....II-50
A Prelude.....II-50
MRI Magnet: A Key Component of MRI System.....II-50
Types of MRI Equipment.....II-50
1$100
   Whole Body Scanners/Closed MRI Systems:.....II-51
Open MRI Systems.....II-51
Dedicated MRI.....II-51
Classification by Magnetic Strength.....II-51
1$100
   Factors Affecting Adoption of MRI Equipment.....II-521$100
   Advantages of MRI Systems.....II-53
Fluoroscopy & Mobile C-Arms.....II-53
An Introduction.....II-53
Process.....II-53
1$100
   Applications.....II-54
Safety Concerns with Fluoroscopy.....II-54
1$100
   Mobile C-Arms.....II-55
Classification by Size.....II-55
Classification by Application.....II-55
1$100
   Contrast Agents.....II-56
How Do They Function?.....II-56
1$100
   Where Are They Used ?.....II-571$100
   GE Healthcare Receives FDA Approval for DaTscan Radiopharmaceutical Agent.....II-58
Targeson Launches Targestar® P-HF Perfusion Contrast Agent.....II-58
Philips Introduces Ingenia MRI Equipment.....II-58
1$100
   Siemens Unveils Biograph mMR and Other Imaging Products.....II-59
Philips Obtains CE Mark Approval for Ingenuity TF PET/MRI System.....II-59
1$100
   Toshiba Obtains FDA Approval for Knee Array Coil for Vantage Titan MR System.....II-60
Bayer Bags FDA Approval for Using Gadobutrol Injection in Diagnostic MRI.....II-60
Digirad Obtains CE Mark for ergo™ Portable Imaging System.....II-60
LI-COR Biosciences Launches Compound Injection Clip.....II-60
BK Medical Launches Innovative Ultrasound Imaging Technology.....II-60
1$100
   LI-COR Unveils IRDye® 800CW HA.....II-61
ChromoTek Introduces GFP-Booster and RFP-Trap®.....II-61
Carestream Health Introduces DRX-Evolution.....II-61
1$100
   NDS Surgical Introduces ZeroWire®.....II-62
UVP Introduces BioDoc-It 210 and BioDoc-It 220 Bioimaging Systems.....II-62
1$100
   NDS Surgical Imaging Unveils ConnectOR™ G2 Informatics and Visualization
  Platform.....II-63
Lantheus Medical Unveils ABLAVAR™ Imaging Agent for MRA.....II-63
Lantheus Medical Introduces DEFINITY® Ultrasound Contrast Imaging Agent in
  India.....II-63
1$100
   Barco Unveils New Range of Display Controllers.....II-64
Diopsys Develops Diopsys® CORDA™ Software.....II-64
1$100
   DICOM Grid Introduces DICOM Grid ImageCare Cloud Computing Platform.....II-65
ContextVision Introduces GOPView® CT Image Enhancement Software.....II-65
Bruker Introduces Icon™ Desktop MRI Scanner.....II-65
1$100
   European Scanning Centre Unveils Aquilion ONE CT 640 Slice Scanner.....II-66
Philips Electronics Introduces GEMINI LXL PET/CT Scanner.....II-66
1$100
   GE Healthcare Receives FDA Approval for Cysview.....II-67
Sanochemia Pharmazeutika Completes DCP Phase of MRT Imaging Agent.....II-67
GE Healthcare Re-Introduces Contrast Agent, Optison™.....II-67
Lantheus Medical Imaging Introduces ABLAVAR™ in Canada.....II-67
1$100
   VisEn Introduces ProSense® 750 FAST and Neutrophil Elastase™ 680 FAST.....II-68
VisEn Medical Unveils VivoTag® 645 Red Fluorescent Dye.....II-68
VisEn Medical Launches VivoTag® 680 XL Fluorescent Dye.....II-68
1$100
   Medtronic Unveils PoleStar N30 MRI System.....II-69
Philips Introduces 3.0T Mobile MRI Solution.....II-69
Siemens Adds MRI Scanners to MoodLight Range.....II-69
1$100
   Toshiba to Upgrade Vantage Titan MR Line with New Advancements.....II-70
Aspect Magnet Technologies to Launch Icon Compact MRI System.....II-70
1$100
   Varian Launches the First Actively Shielded UHF MRI 7 Tesla Magnet.....II-71
Toshiba to Introduce M-Power User Interface.....II-71
OrthoScan Introduces New Mini C-Arm.....II-71
1$100
   Leica Microsystems Develops Leica DMI6000 B.....II-72
Leica Microsystems Introduces Two HD Imaging Products.....II-72
Nikon Launches Mi Macro Imaging Tool.....II-72
GE Healthcare Receives FDA Approval for Vivid™ E9 Breakthrough 2011.....II-72
1$100
   GE Healthcare Launches Affordable GE Centricity PACS Reach for India.....II-73
GE Healthcare Introduces PET Radiopharmacy Solutions.....II-73
1$100
   GE Healthcare Adds New Capabilities to LOGIQ E9 Platform.....II-74
GE Healthcare Introduces Healthcare Products.....II-74
1$100
   Carestream Introduces Gel Logic 2200 PRO Optical Imaging System.....II-75
QImaging® Launches the EXi AQUA™ Microscopy Camera.....II-75
1$100
   Kapelan Introduces LabImage 1D for MAC OS X.....II-76
Photometrics® Unveils Evolve™ EMCCD Camera.....II-76
VisEn Unveils Annexin-Vivo 750 Imaging Agent.....II-76
VisEn Unveils VivoTag® 800 and OsteoSense® 800 Imaging Agents.....II-76
1$100
   Alseres Obtains SPA agreement from FDA.....II-77
Neusoft Launches NeuViz 16 Multi-Slice CT Scanner.....II-77
Metris Introduces New High-Power CT/X-ray System.....II-77
1$100
   SCANCO Medical Introduces Novel microCT Systems.....II-78
Siemens to Introduce SOMATOM Definition Flash in the Middle East.....II-78
GE Healthcare Debuts Pioneering HD CT Scanner.....II-78
Toshiba Launches Two Multi-Detector CT Systems.....II-78
1$100
   Neusoft Medical Receives FDA Approval for New CT System.....II-79
Neuisys Receives FDA Approval for NeuViz 16 Multi Slice CT Solution.....II-79
Digirad Corporation Receives FDA Approval for Cardius® X-ACT Imager.....II-79
1$100
   Siemens Receives FDA Approval for New 16 Slice PET•CT System.....II-80
NeuroLogica Obtains Approval for Marketing CereTom in Brazil.....II-80
Royal Philips Launches BrightView X Mid-level SPECT Camera.....II-80
1$100
   Philips Unveils GEMINI TF PET/CT for Oncology Applications.....II-81
Siemens Introduces c.cam SPECT System.....II-81
Dilon Technologies Unveils New Collimators.....II-81
Positron Introduces PosiRx Solution.....II-81
Naviscan Unveils High-resolution PET Scanner with PEM Biopsy Capability.....II-81
1$100
   Digirad Bags FDA Clearance for Portable Imaging System.....II-82
VisEn Medical Introduces ReninSense680™ FAST.....II-82
VisEn Introduces New Fluorescence Molecular Imaging Agent, IntegriSense™ 750.....II-82
1$100
   SonoSite Introduces the Nanomaxx™ Ultrasound System.....II-83
Toshiba Medical Unveils Aplio MX Compact Ultrasound System.....II-83
GE Launches Handheld Ultrasound Machine.....II-83
MEDISON Launches New OB/GYN Ultrasound System.....II-83
1$100
   Biosound Unveils MyLab® Ultrasound Systems Line for OBS.....II-84
Olympus Medical Systems to Introduce EU-ME1.....II-84
Philips Rolls Out HD9 Ultrasound System.....II-84
B K Medical Launches New Urological and Surgical Ultrasound Systems.....II-84
1$100
   Time Medical Receives FDA Clearance for Open MRI System, Pica 0.35T.....II-85
GE Healthcare Unveils Latest 1.5T MRI Equipment in the Middle East.....II-85
GE Healthcare to Debut Medical Imaging Equipment Incorporating Broader Tube.....II-85
1$100
   Varian and GE Healthcare Introduce Discovery™ MR901 Pre-Clinical MRI Machine.....II-86
ONI Medical Systems Installs MSK Extreme® 1.5T MRI Machine.....II-86
Confirma Launches Advanced MRI CAD OS in Canada.....II-86
Medtronic Launches PoleStar N30 Surgical MRI System.....II-86
1$100
   Varian and GE Healthcare Launch Discovery MR901.....II-87
Hitachi Launches OASIS Open MRI System in Japan.....II-87
Hitachi Unveils AIRIS Vento Open MRI System.....II-87
GE Receives FDA and CE Mark Clearance for Discovery MR450 MRI System.....II-87
1$100
   Siemens Introduces Magnetom Espree-Pink MRI Breast Scanner.....II-88
IMRIS Obtains European CE Mark Certification for IMRISNV and IMRIScardio.....II-88
Philips Introduces Veradius X-Ray System.....II-88
1$100
   Ziehm Imaging Bags FDA Approval for Ziehm Vision RFD Mobile C-Arm.....II-891$100
   Toshiba Medical Systems to Take Over Vital Images.....II-90
GE Healthcare Acquires SSI.....II-90
RadNet Acquires Imaging Centers from Presgar Imaging.....II-90
RadNet Acquires Imaging On Call.....II-90
1$100
   GE Healthcare Acquires Orbotech Medical Solutions.....II-91
Brainlab and SurgiVision Collaborate for iMRI Guided Therapies.....II-91
TMIC Performs First PET.CT Scan in the UAE.....II-91
1$100
   Swansea University Selects Siemens’ Imaging Systems.....II-92
Nikon Instruments Inks Pact with Agilent.....II-92
GE Healthcare Enters into Three-Year Agreement with Novation.....II-92
1$100
   Hitachi Medical Acquires Aloka.....II-93
Andor Technology Takes Over Photonic Instruments.....II-93
Cascade Technologies Acquires Spectral Molecular Imaging.....II-93
ICON Takes Over Timaq Medical Imaging.....II-93
1$100
   RadNet Acquires Truxtun Medical Group.....II-94
Eli Lilly Acquires Avid Radiopharmaceuticals.....II-94
CAMC to Acquire Mountaineer Imaging.....II-94
Hologic Acquires Sentinelle Medical.....II-94
1$100
   Bard to Acquire SenoRx.....II-95
Carestream Health Takes Over Quantum Medical Imaging.....II-95
SonoSite Takes Over VisualSonics.....II-95
Hologic Takes Over Sentinelle Medical.....II-95
1$100
   Agfa Healthcare Snaps Up Insight Agents.....II-96
Leica Microsystems Takes Over Genetix.....II-96
Varian Medical Closes an Agreement with IMRIS.....II-96
Covidien Inks Agreement with IAE POLATOM to Supply Mo 99.....II-96
FEI Collaborates with Nanonics.....II-96
1$100
   Carestream Molecular Imaging and OncoVision Enter into an Agreement.....II-97
GE Healthcare Inks Agreement with Nycomed.....II-97
Nordion to Divest MDS Nordion.....II-97
1$100
   GE Healthcare Expands Company’s CT Manufacturing Facility in Bangalore.....II-98
Lantheus Medical Imaging Enters into Agreement with Amerinet.....II-98
Hologic Inks Partnership Agreement with Super Sonic Imagine.....II-98
GE Healthcare and ZAO Medical Partner to Produce Diagnostic Imaging Products.....II-98
1$100
   GE Secures NIH Grant to Develop Nerve Imaging Agent and Imaging System.....II-99
Avid Partners with PETNET Solutions for Production of Florbetapir F 18.....II-99
Lantheus Purchases MS-325 Related Rights from EPIX Pharmaceuticals.....II-99
Siemens Bags Multiple Orders for MRI Systems in the UK.....II-99
1$100
   Bruker Corporation Bags Contract for Field MRI CryoProbe.....II-100
Rwanda Government to Purchase MRI Systems.....II-100
Positron Receives Additional Orders for Attrius® PET Scanners.....II-100
Definiens and Philips to Develop Digital Pathology System for Cancer
  Diagnosis.....II-100
1$100
   PerkinElmer and LinaTech Sign Joint Technology Marketing and Development
  Agreement.....II-101
Olympus America Signs Licensing Agreement with BioImagene.....II-101
Andor Technology Takes Over Bitplane.....II-101
1$100
   BioClinica Acquires Agfa HealthCare's CardioNow Unit.....II-102
Toptica Photonics Acquires Till Photonics.....II-102
Medical Imaging Holdings Acquires Sonora Medical Systems from Misonix.....II-102
1$100
   Digirad Inks Asset Purchase Agreement with MD Office Solutions.....II-103
Siemens and SurgiVision to Co-Develop MRI- Guided EP System.....II-103
GE Healthcare, HHS and Tel Aviv Sourasky Medical Center Collaborate.....II-103
1$100
   Metavante Acquires CapMed Division of BioClinica.....II-104
GE Establishes Molecular Imaging Business Unit.....II-104
Siemens Healthcare and EDPL to Jointly Set Up Cyclotron Facility.....II-104
Positron Inks Agency Agreement with TIS.....II-104
FEI’s Cryo-Electron Microscope Achieves Atomic Resolution of Viruses.....II-104
1$100
   IBA Enters Collaborates with Aposense to Commercialize [18F]-ML-10.....II-105
Eckert & Ziegler Divests FCI Contrast Media Business.....II-105
Babcock and Mallinckrodt Jointly Develop Molybdenum-99.....II-105
1$100
   Midwest Ultrasound Inks Partnership Agreement with Toshiba America.....II-106
Dilon Diagnostics Inks Distribution Agreement with Royal Philips.....II-106
GE Healthcare Installs First High-definition CT Scanner in Russia.....II-106
1$100
   IMRIS to Deploy Asia’s First 3T IMRIS System at Huashan Hospital.....II-107
Agilent Acquires TILL Photonics.....II-107
Avista Capital Partners Acquires Bristol-Myers Squibb Medical Imaging.....II-107
1$100
   Bayer HealthCare Pharmaceuticals (Germany).....II-108
Bracco Imaging S.p.A (Italy).....II-108
Covidien Pharmaceuticals (US).....II-108
1$100
   Digirad Corporation (US).....II-109
Esaote S.p.A (Italy).....II-109
1$100
   FONAR Corporation (US).....II-110
Gamma Medica, Inc. (US).....II-110
GE Healthcare (UK).....II-110
1$100
   Hitachi Medical Corporation (Japan).....II-111
Hologic, Inc. (US).....II-111
1$100
   Lantheus Medical Imaging, Inc. (US).....II-112
Samsung Medison Co., Ltd. (South Korea).....II-112
Mindray Medical International Limited (China).....II-112
1$100
   Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China).....II-113
Philips Healthcare (The Netherlands).....II-113
Positron Corporation (US).....II-113
1$100
   Shimadzu Corporation (Japan).....II-114
Siemens Healthcare (Germany).....II-114
1$100
   SonoSite, Inc. (US).....II-115
Toshiba Medical Systems Corporation (Japan).....II-115
Toshiba America Medical Systems, Inc. (US).....II-115
1$100
   Table 2: World Recent Past, Current and Future Analysis for Bioimaging Technologies by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, and Rest of World Markets Independently Analyzed by Annual Sales Figures in US$ Million for the Years 2009 through 2017 (includes corresponding Graph/Chart).....II-1161$350
   Table 3: World Historic Review for Bioimaging Technologies by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, and Rest of World Markets Independently Analyzed by Annual Sales Figures in US$ Million for the Years 2003 through 2008 (includes corresponding Graph/Chart).....II-1171$350
   Table 4: World 15-Year Perspective for Bioimaging Technologies by Geographic Region - Percentage Breakdown of Value Sales for US, Canada, Japan, Europe, Asia-Pacific, and Rest of World Markets for the Years 2003, 2010 and 2017 (includes corresponding Graph/Chart).....II-1181$350
   Table 5: World Recent Past, Current and Future Analysis for Medical Bioimaging by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, and Rest of World Markets Independently Analyzed by Annual Sales Figures in US$ Million for the Years 2009 through 2017 (includes corresponding Graph/Chart).....II-1191$350
   Table 6: World Historic Review for Medical Bioimaging by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, and Rest of World Markets Independently Analyzed by Annual Sales Figures in US$ Million for the Years 2003 through 2008 (includes orresponding Graph/Chart).....II-1201$350
   Table 7: World 15-Year Perspective for Medical Bioimaging Technologies by Geographic Region - Percentage Breakdown of Value Sales for US, Canada, Japan, Europe, Asia-Pacific, and Rest of World Markets for the Years 2003, 2010 and 2017 (includes corresponding Graph/Chart).....II-1211$350
   Table 8: World Recent Past, Current and Future Analysis for Molecular Bioimaging by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, and Rest of World Markets Independently Analyzed by Annual Sales Figures in US$ Million for the Years 2009 through 2017 (includes corresponding Graph/Chart).....II-1221$350
   Table 9: World Historic Review for Molecular Bioimaging by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, and Rest of World Markets Independently Analyzed by Annual Sales Figures in US$ Million for the Years 2003 through 2008 (includes corresponding Graph/Chart).....II-1231$350
   Table 10: World 15-Year Perspective for Molecular Bioimaging Technologies by Geographic Region - Percentage Breakdown of Value Sales for US, Canada, Japan, Europe, Asia-Pacific, and Rest of World Markets for the Years 2003, 2010 and 2017 (includes corresponding Graph/Chart).....II-1241$350
   A. Market Analysis.....II-125
Outlook.....II-125
Diagnostic Imaging Market: Recession and Beyond.....II-125
1$100
   Healthcare Reforms & Reimbursements: Key Influencing Factors.....II-126
Competitive Landscape.....II-126
Bright Future Awaits Molecular Bioimaging Systems Market Post-Recession.....II-126
1$100
   X-Ray Imaging Market.....II-127
Digital Technology Propels X-Ray Market.....II-127
MRI Systems Market.....II-127
High-Field MRI Systems Gaining Significance.....II-127
1$100
   MRI Imaging Centers Feel the Heat during Recession.....II-128
Technological Advancements to Drive Market.....II-128
The Impact of Healthcare Reforms.....II-128
1$100
   Reimbursement Scenario.....II-129
Competitive Scenario.....II-129
CT Market.....II-129
1$100
   Multi-Slice Scanners Outpace Single-Slice Systems.....II-130
64-Slice CT Market to Register Growth.....II-130
FDA Regulations for CT Imaging Systems.....II-130
1$100
   Ultrasound Imaging Systems Market.....II-131
A Commodity Market.....II-131
Technological Developments to Drive Growth.....II-131
HCU Equipment: Potential Opportunities in Cardiology Sector.....II-131
1$100
   Handheld Systems Drive Growth in the Ultrasound Market.....II-132
Increased Adoption in Non-Hospitals Settings.....II-132
High Growth of Ultrasound Technology Market.....II-132
Rising Demand for Ultrasound Technicians.....II-132
1$100
   Ultrasound Contrast Agents (UCA).....II-133
Nuclear Medicine Imaging Users Shift to Integrated Systems.....II-133
Economic Crisis and New Regulatory Initiatives Play Spoilsport.....II-133
1$100
   PET Capabilities Widen with CT.....II-134
PET Imaging Systems Market: Past and Present Scenario.....II-134
Emergence of PET for New Conditions.....II-134
Rising Demand for PET in Radiation Oncology.....II-134
1$100
   Users Opt for PET Systems over SPECT for MPI.....II-135
Increased Focus on Value-Based PET/CT Systems.....II-135
Development of Hybrid PET Systems.....II-135
1$100
   PET/CT Market: Factors Affecting Commercialization.....II-136
Referral Base.....II-136
Reimbursement Concerns.....II-136
Contrast Agents and Contrast Agent Injectors.....II-136
The Role of Reimbursements.....II-136
1$100
   Product Innovations/Introductions.....II-13719$375
   Strategic Corporate Developments.....II-1568$175
   Key Players.....II-1644$175
   B. Market Analytics.....II-168
Table 11: US Recent Past, Current and Future Analysis for Bioimaging Technologies by Product Segment - Medical Bioimaging and Molecular Bioimaging Markets Independently Analyzed with Annual Sales Figures in US$ Million for the Years 2009 through 2017 (includes corresponding Graph/Chart).....II-168
1$350
   Table 12: US Historic Review for Bioimaging Technologies by Product Segment - Medical Bioimaging and Molecular Bioimaging Markets Independently Analyzed with Annual Sales Figures in US$ Million for the Years 2003 through 2008 (includes corresponding Graph/Chart).....II-1691$350
   Table 13: US 15-Year Perspective for Bioimaging Technologies by Product Segment - Percentage Breakdown of Value Sales for Medical Bioimaging and Molecular Bioimaging Markets for the Years 2003, 2010 and 2017 (includes corresponding Graph/Chart).....II-1701$350
   A. Market Analysis.....II-171
Outlook.....II-171
Medical Imaging: Improving Efficiency of Healthcare Systems.....II-171
Types of Imaging Equipment in Use.....II-171
1$100
   Recession Hits Imaging Industry.....II-172
CT and MRI Usage in Canada.....II-172
1$100
   MRI Market: Technology Advancements Spur Growth.....II-173
Hybrid Modalities: Potential for Growth.....II-173
Miniaturization and Increase in Computing Power.....II-173
3D/4D imaging and Computer-Aided Detection.....II-173
Challenges Facing Imaging Systems Marketm.....II-173
Technological Constraints.....II-173
1$100
   Regulatory and Legal Restrictions.....II-174
Health Act: Providing Health to All.....II-174
Opportunities for US Manufacturers.....II-174
Competitive Landscape.....II-174
1$100
   Table 14: Leading Players in the Canadian Diagnostic Imaging Equipment Market (2009): Percentage Share Breakdown of Value Sales for GE Healthcare, Philips Medical Systems, Siemens Medical Solutions, Hologic Inc., Toshiba Medical Systems, SonoSite, and Others (includes corresponding Graph/Chart).....II-175
Product Innovations/Introductions.....II-175
2$350
   Strategic Corporate Developments.....II-1771$100
   B. Market Analytics.....II-178
Table 15: Canadian Recent Past, Current and Future Analysis for Bioimaging Technologies by Product Segment - Medical Bioimaging and Molecular Bioimaging Markets Independently Analyzed with Annual Sales Figures in US$ Million for the Years 2009 through 2017 (includes corresponding Graph/Chart).....II-178
1$350
   Table 16: Canadian Historic Review for Bioimaging Technologies by Product Segment - Medical Bioimaging and Molecular Bioimaging Markets Independently Analyzed with Annual Sales Figures in US$ Million for the Years 2003 through 2008 (includes corresponding Graph/Chart).....II-1791$350
   Table 17: Canadian 15-Year Perspective for Bioimaging Technologies by Product Segment - Percentage Breakdown of Value Sales for Medical Bioimaging and Molecular Bioimaging Markets for the Years 2003, 2010 and 2017 (includes corresponding Graph/Chart).....II-1801$350
   A. Market Analysis.....II-181
Outlook.....II-181
Japanese Healthcare System: An Overview.....II-181
Fast Facts.....II-181
Government Initiatives.....II-181
1$100
   Product Innovations/Introductions.....II-1821$100
   Strategic Corporate Developments.....II-1831$100
   Key Players.....II-1842$125
   B. Market Analytics.....II-186
Table 18: Japanese Recent Past, Current and Future Analysis for Bioimaging Technologies by Product Segment - Medical Bioimaging and Molecular Bioimaging Markets Independently Analyzed with Annual Sales Figures in US$ Million for the Years 2009 through 2017 (includes corresponding Graph/Chart).....II-186
1$350
   Table 19: Japanese Historic Review for Bioimaging Technologies by Product Segment - Medical Bioimaging and Molecular Bioimaging Markets Independently Analyzed with Annual Sales Figures in US$ Million for the Years 2003 through 2008 (includes corresponding Graph/Chart).....II-1871$350
   Table 20: Japanese 15-Year Perspective for Bioimaging Technologies by Product Segment - Percentage Breakdown of Value Sales for Medical Bioimaging and Molecular Bioimaging Markets for the Years 2003, 2010 and 2017 (includes corresponding Graph/Chart).....II-1881$350
   A. Market Analysis.....II-189
Outlook.....II-189
Hybrid Technology to Sustain Molecular Bioimaging Systems Market.....II-189
Refurbished Market Gains Momentum.....II-189
Challenges Facing European Bioimaging Market.....II-189
Pricing Pressures.....II-189
1$100
   Reimbursement Issue.....II-190
Regulations for Imaging Equipment.....II-190
Ultrasound Imaging Market.....II-190
Saturating Conditions Typify Ultrasound Imaging Market.....II-190
Cost Saving Measures Gain Prominence.....II-190
1$100
   Handheld Echocardiographs: Future of Cardiac Ultrasound Imaging.....II-191
Miniature Echocardiography Systems.....II-191
Focus Shifts to Automated Image Analysis.....II-191
Ultrasound Majors and Research Institutes Collaborate.....II-191
Women’s Health Imaging Market in Europe: Overview.....II-191
1$100
   Growing Adoption of Screening Programs Drives Mammography Sector.....II-192
Shortage of Funds: A Major Challenge.....II-192
Nuclear Imaging Market.....II-192
MRI Market.....II-192
1$100
   European PACS Market.....II-1931$100
   Radiology: The Predominant Segment.....II-194
Technological Advancements Foster Growth.....II-194
High Significance of Government Initiatives.....II-194
Teleradiology: Symbiotic Relationship with PACS.....II-194
1$100
   Benefiting from Modular Approach of Image Management Systems.....II-195
Competitive Landscape.....II-195
Euro-BioImaging Improves Bioimaging in Europe.....II-195
Product Innovations/Introductions.....II-195
2$125
   B. Market Analytics.....II-197
Table 21: European Recent Past, Current and Future Analysis for Bioimaging Technologies by Geographic Region - France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for the Years 2009 through 2017 (includes corresponding Graph/Chart).....II-197
1$350
   Table 22: European Historic Review for Bioimaging Technologies by Geographic Region - France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for the Years 2003 through 2008 (includes corresponding Graph/Chart).....II-1981$350
   Table 23: European 15-Year Perspective for Bioimaging Technologies by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets for the Years 2003, 2010 and 2017 (includes corresponding Graph/Chart).....II-1991$350
   Table 24: European Recent Past, Current and Future Analysis for Bioimaging Technologies by Product Segment - Medical Bioimaging and Molecular Bioimaging Markets Independently Analyzed with Annual Sales Figures in US$ Million for the Years 2009 through 2017 (includes corresponding Graph/Chart).....II-2001$350
   Table 25: European Historic Review for Bioimaging Technologies by Product Segment - Medical Bioimaging and Molecular Bioimaging Markets Independently Analyzed with Annual Sales Figures in US$ Million for the Years 2003 through 2008 (includes corresponding Graph/Chart).....II-2011$350
   Table 26: European 15-Year Perspective for Bioimaging Technologies by Product Segment - Percentage Breakdown of Value Sales for Medical Bioimaging and Molecular Bioimaging Markets for the Years 2003, 2010 and 2017 (includes corresponding Graph/Chart).....II-2021$350
   Market Analysis.....II-203
Table 27: French Recent Past, Current and Future Analysis for Bioimaging Technologies by Product Segment - Medical Bioimaging and Molecular Bioimaging Markets Independently Analyzed with Annual Sales Figures in US$ Million for the Years 2009 through 2017 (includes corresponding Graph/Chart).....II-203
1$350
   Table 28: French Historic Review for Bioimaging Technologies by Product Segment – Medical Bioimaging and Molecular Bioimaging Markets Independently Analyzed with Annual Sales Figures in US$ Million for the Years 2003 through 2008 (includes corresponding Graph/Chart).....II-2041$350
   Table 29: French 15-Year Perspective for Bioimaging Technologies by Product Segment - Percentage Breakdown of Value Sales for Medical Bioimaging and Molecular Bioimaging Markets for the Years 2003, 2010 and 2017 (includes corresponding Graph/Chart).....II-2051$350
   A. Market Analysis.....II-206
Outlook.....II-206
Product Innovations/Introductions.....II-206
3$175
   Strategic Corporate Developments.....II-2091$100
   Key Players.....II-2102$125
   B. Market Analytics.....II-212
Table 30: German Recent Past, Current and Future Analysis for Bioimaging Technologies by Product Segment - Medical Bioimaging and Molecular Bioimaging Markets Independently Analyzed with Annual Sales Figures in US$ Million for the Years 2009 through 2017 (includes corresponding Graph/Chart).....II-212
1$350
   Table 31: German Historic Review for Bioimaging Technologies by Product Segment - Medical Bioimaging and Molecular Bioimaging Markets Independently Analyzed with Annual Sales Figures in US$ Million for the Years 2003 through 2008 (includes corresponding Graph/Chart).....II-2131$350
   Table 32: German 15-Year Perspective for Bioimaging Technologies by Product Segment - Percentage Breakdown of Value Sales for Medical Bioimaging and Molecular Bioimaging Markets for the Years 2003, 2010 and 2017 (includes corresponding Graph/Chart).....II-2141$350
   A. Market Analysis.....II-215
Outlook.....II-215
Strategic Corporate Developments.....II-215
Key Players.....II-215
2$125
   B. Market Analytics.....II-217
Table 33: Italian Recent Past, Current and Future Analysis for Bioimaging Technologies by Product Segment - Medical Bioimaging and Molecular Bioimaging Markets Independently Analyzed with Annual Sales Figures in US$ Million for the Years 2009 through 2017 (includes corresponding Graph/Chart).....II-217
1$350
   Table 34: Italian Historic Review for Bioimaging Technologies by Product Segment – Medical Bioimaging and Molecular Bioimaging Markets Independently Analyzed with Annual Sales Figures in US$ Million for the Years 2003 through 2008 (includes corresponding Graph/Chart).....II-2181$350
   Table 35: Italian 15-Year Perspective for Bioimaging Technologies by Product Segment - Percentage Breakdown of Value Sales for Medical Bioimaging and Molecular Bioimaging Markets for the Years 2003, 2010 and 2017 (includes corresponding Graph/Chart).....II-2191$350
   A. Market Analysis.....II-220
Outlook.....II-220
Product Innovations/Introductions.....II-220
1$100
   Strategic Corporate Developments.....II-2211$100
   Key Players.....II-2221$100
   B. Market Analytics.....II-223
Table 36: UK Recent Past, Current and Future Analysis for Bioimaging Technologies by Product Segment - Medical Bioimaging and Molecular Bioimaging Markets Independently Analyzed with Annual Sales Figures in US$ Million for the Years 2009 through 2017 (includes corresponding Graph/Chart).....II-223
1$350
   Table 37: UK Historic Review for Bioimaging Technologies by Product Segment - Medical Bioimaging and Molecular Bioimaging Markets Independently Analyzed with Annual Sales Figures in US$ Million for the Years 2003 through 2008 (includes corresponding Graph/Chart).....II-2241$350
   Table 38: UK 15-Year Perspective for Bioimaging Technologies by Product Segment - Percentage Breakdown of Value Sales for Medical Bioimaging and Molecular Bioimaging Markets for the Years 2003, 2010 and 2017 (includes corresponding Graph/Chart).....II-2251$350
   Market Analysis.....II-226
Table 39: Spanish Recent Past, Current and Future Analysis for Bioimaging Technologies by Product Segment - Medical Bioimaging and Molecular Bioimaging Markets Independently Analyzed with Annual Sales Figures in US$ Million for the Years 2009 through 2017 (includes corresponding Graph/Chart).....II-226
1$350
   Table 40: Spanish Historic Review for Bioimaging Technologies by Product Segment - Medical Bioimaging and Molecular Bioimaging Markets Independently Analyzed with Annual Sales Figures in US$ Million for the Years 2003 through 2008 (includes corresponding Graph/Chart).....II-2271$350
   Table 41: Spanish 15-Year Perspective for Bioimaging Technologies by Product Segment - Percentage Breakdown of Value Sales for Medical Bioimaging and Molecular Bioimaging Markets for the Years 2003, 2010 and 2017 (includes corresponding Graph/Chart).....II-2281$350
   A. Market Analysis.....II-229
Outlook.....II-229
Strategic Corporate Developments.....II-229
2$125
   B. Market Analytics.....II-231
Table 42: Russian Recent Past, Current and Future Analysis for Bioimaging Technologies by Product Segment - Medical Bioimaging and Molecular Bioimaging Markets Independently Analyzed with Annual Sales Figures in US$ Million for the Years 2009 through 2017 (includes corresponding Graph/Chart).....II-231
1$350
   Table 43: Russian Historic Review for Bioimaging Technologies by Product Segment - Medical Bioimaging and Molecular Bioimaging Markets Independently Analyzed with Annual Sales Figures in US$ Million for the Years 2003 through 2008 (includes corresponding Graph/Chart).....II-2321$350
   Table 44: Russian 15-Year Perspective for Bioimaging Technologies by Product Segment - Percentage Breakdown of Value Sales for Medical Bioimaging and Molecular Bioimaging Markets for the Years 2003, 2010 and 2017 (includes corresponding Graph/Chart).....II-2331$350
   A. Market Analysis.....II-234
Outlook.....II-234
Product Introductions/Innovations.....II-234
4$175
   Strategic Corporate Developments.....II-2383$150
   B. Market Analytics.....II-241
Table 45: Rest of Europe Recent Past, Current and Future Analysis for Bioimaging Technologies by Product Segment - Medical Bioimaging and Molecular Bioimaging Markets Independently Analyzed with Annual Sales Figures in US$ Million for the Years 2009 through 2017 (includes corresponding Graph/Chart).....II-241
1$350
   Table 46: Rest of Europe Historic Review for Bioimaging Technologies by Product Segment - Medical Bioimaging and Molecular Bioimaging Markets Independently Analyzed with Annual Sales Figures in US$ Million for the Years 2003 through 2008 (includes corresponding Graph/Chart).....II-2421$350
   Table 47: Rest of Europe 15-Year Perspective for Bioimaging Technologies by Product Segment - Percentage Breakdown of Value Sales for Medical Bioimaging and Molecular Bioimaging Markets for the Years 2003, 2010 and 2017 (includes corresponding Graph/Chart).....II-2431$350
   A. Market Analysis.....II-244
Outlook.....II-244
Medical Tourism Drives Demand for Medical Imaging Systems.....II-244
Patient Focus Shifts to Preventive Healthcare.....II-244
1$100
   Imaging Modalities: Areas of Opportunities.....II-245
Ultrasound Imaging.....II-245
3D/4D Imaging: Opening New Clinical Uses for Ultrasound Systems.....II-245
Integrated Medical Imaging Technologies.....II-245
Digital Imaging.....II-245
Mammography.....II-245
1$100
   MRI Systems.....II-246
China.....II-246
Medical Imaging Device Market - Overview.....II-246
1$100
   Increasing Expenditure on Healthcare Sector.....II-247
Tier 2 & 3 Hospitals: Controlling Import Market.....II-247
High Demand for Imported Equipment in Guangzhou, Shanghai, and Beijing
  Regions.....II-247
1$100
   Low Penetration Marks Other Regions.....II-248
Low Demand for China-Made Imaging Equipment.....II-248
1$100
   Advanced Equipment to Find Favor.....II-249
Second Hand Medical Imaging: A Non-Existent Market.....II-249
Lack of Guidelines for Replacing Imaging Equipment.....II-249
Stringent Controls on Procurement of Imaging Equipment.....II-249
1$100
   Foreign Suppliers Rule the Market.....II-2501$100
   Domestic Companies Look to Expand Presence.....II-251
An Insight into China’s Ultrasound Imaging Market.....II-251
Color Systems & Government Support: Vital Growth Factors.....II-251
1$100
   Portable Ultrasound Diagnostic Imaging Systems Find Favor.....II-252
Competitive Landscape.....II-252
Table 48: Leading Manufacturers in the Chinese Black & White Ultrasound Market (2009): Percentage Share Breakdown of Revenues for Mindray, Philips, GE and Others (includes corresponding Graph/Chart).....II-252
MRI Market in China.....II-252
1$350
   Table 49: Leading Players in China’s MRI Market (2010): Percentage Share Breakdown of Revenues for Xingaoyi, Neusoft, Wandong, Foreign Brands, and Other Local Brands (includes corresponding Graph/Chart).....II-253

Table 50: Leading Manufacturers in the China’s MRI Market (2010): Percentage Share Breakdown of Volume Shipment for Siemens, GE, Philips, Toshiba/Shimadzu, Xingaoyi, Neusoft, Wandong and Others (includes corresponding Graph/Chart).....II-253
1$350
   Table 51: Select Models of Local MRI Manufacturers in China.....II-254

Table 52: Select Models of Foreign MRI Manufacturers.....II-254
India.....II-254
A High Potential Market for Bioimaging Systems.....II-254
1$350
   CT Imaging Market in India.....II-255
At a Glance.....II-255
1$100
   Radiology and Cardiology: Forefront of CT Modality.....II-256
Table 53: CT Scanners Market in India by Segment (2010): Percentage Share Breakdown of Value Sales for Cardiology & Other High-End Segments, Value Segment (includes 2/4/6/8 Slice CT systems), Non-Cardiac and Radiological High-End Segment, Entry-Level Segment, and Refurbished/Used Equipment Segment (includes corresponding Graph/Chart).....II-256
Growing Popularity of Multi-Slice Scanners.....II-256
1$350
   Pricing: The Prime Competitive Factor.....II-257
Technological Advancements Drive Growth.....II-257
Addressing the Drawbacks of Thinner Slices.....II-257
Preventive Screening Centers to Revitalize CT Market.....II-257
1$100
   Rising Demand for Refurbished Equipment from Private Sector.....II-258
Competitive Landscape.....II-258
Ultrasound Imaging Equipment Market.....II-258
Cardiology & Radiology: Leading Application Areas.....II-258
Portable Devices Drive Growth.....II-258
1$100
   Color Dopplers Gain Prominence.....II-259
PNDT Act: The Challenge for Ultrasound Systems Market.....II-259
Competitive Landscape.....II-259
1$100
   MRI Equipment Market – An Overview.....II-260
Product Innovations/Introductions.....II-260
1$100
   Strategic Corporate Developments.....II-2611$100
   Key Players.....II-2622$125
   B. Market Analytics.....II-264
Table 54: Asia-Pacific Recent Past, Current and Future Analysis for Bioimaging Technologies by Product Segment - Medical Bioimaging and Molecular Bioimaging Markets Independently Analyzed with Annual Sales Figures in US$ Million for the Years 2009 through 2017 (includes corresponding Graph/Chart).....II-264
1$350
   Table 55: Asia-Pacific Historic Review for Bioimaging Technologies by Product Segment - Medical Bioimaging and Molecular Bioimaging Markets Independently Analyzed with Annual Sales Figures in US$ Million for the Years 2003 through 2008 (includes corresponding Graph/Chart).....II-2651$350
   Table 56: Asia-Pacific 15-Year Perspective for Bioimaging Technologies by Product Segment - Percentage Breakdown of Value Sales for Medical Bioimaging and Molecular Bioimaging Markets for the Years 2003, 2010 and 2017 (includes corresponding Graph/Chart).....II-2661$350
   A. Market Analysis.....II-267
Outlook.....II-267
Kenya.....II-267
Ultrasound Imaging Technology in Kenya.....II-267
Product Innovations/Introductions.....II-267
2$125
   Strategic Corporate Developments.....II-2691$100
   B. Market Analytics.....II-270
Table 57: Rest of World Recent Past, Current and Future Analysis for Bioimaging Technologies by Product Segment - Medical Bioimaging and Molecular Bioimaging Markets Independently Analyzed with Annual Sales Figures in US$ Million for the Years 2009 through 2017 (includes corresponding Graph/Chart).....II-270
1$350
   Table 58: Rest of World Historic Review for Bioimaging Technologies by Product Segment - Medical Bioimaging and Molecular Bioimaging Markets Independently Analyzed with Annual Sales Figures in US$ Million for the Years 2003 through 2008 (includes corresponding Graph/Chart).....II-2711$350
   Table 59: Rest of World 15-Year Perspective for Bioimaging Technologies by Product Segment - Percentage Breakdown of Value Sales for Medical Bioimaging and Molecular Bioimaging Markets for the Years 2003, 2010 and 2017 (includes corresponding Graph/Chart).....II-2721$350
    
 
 


Sales queries: Sales@StrategyR.com
Research queries: Info411@StrategyR.com